The risk of Guillain-Barre syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States

American Journal of Public Health

Volumn 87, Issue 12, 1997, Pages 2045-2048

  Tuttle, Jessica ^a   Chen, Robers T ^a   Rantala, Heikki ^b   Cherry, James D ^c   Rhodes, Philip H ^a   Hadler, Stephen ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; TETANUS TOXOID;

ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; TETANUS PROPHYLAXIS;

EID: 0031469230     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.87.12.2045     Document Type: Article

References (17)

1. The National Childhood Vaccine Injury Act of 1986, at Section 2125 of the Public Health Service Act as codified at 42 USC §300aa-(suppl 1987).
2. Howson CP, Howe CJ, Fineberg HV, eds. Adverse Events of Pertussis and Rubella Vaccines. Washington, DC: Institute of Medicine, National Academy Press; 1991.
3. Stratton KR, Howe CJ, Johnston RB, eds. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: Institute of Medicine, National Academy Press; 1994.
4. Centers for Disease Control and Prevention. Biologics Surveillance Report No. 94, 1991-1995. Atlanta, Ga: Centers for Disease Control and Prevention, 1997.
5. Chen R, Kent J, Rhodes P, et al. Investigation of a possible association between influenza vaccination and Guillain-Barré syndrome in the United States, 1990-1991. Post Marketing Surveill. 1992;6:5-6. Abstract.
6. Asbury AK, Arnason BGW, Karp HR, et al. Criteria for diagnosis of Guillain-Barre syndrome. Ann Neurol. 1978;3:565-566.
7. National Health Interview Survey of Child Health, 1991. Hyattsville, Md: National Center for Health Statistics; 1992. Machine readable public-use data file and documentation.
8. County Population for 1990 by State, vol 1. Washington, DC: Bureau of the Census; 1991:279. CPH l-11-tables. (DHHS publication PHS 91-1260).
9. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol. 1979;110:105-123.
10. Rantala H, Cherry JD, Shields WD, et al. Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence. J Pediatr. 1994;124:220-223.
11. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States, January 1995. MMWR Morb Mortal Wkfy Rep. 1995;43:959-960.
12. Centers for Disease Control and Prevention. Vaccination coverage of 2-year-old children - United States, 1991-1992. MMWR Morb Mortal Wkly Rep. 1994;42:985-988.
13. StatXact-Turbo User Manual. Cambridge, Mass: Cytel Software Corp; 1992.
14. Hankey GJ. Guillain-Barré syndrome in Western Australia 1980-1985. Med J Aust. 1987;146:13-133.
15. Winer JB, Hughes RA, Anderson MJ, et al. A prospective study of acute idiopathic neuropathy: II. antecedent events. J Neurol, Neurosurg Psychiatry. 1988;51:633-618.
16. Safranek TJ, Lawrence DN, Kurland LT, et al. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977. Results of a two-state study. Am J Epidemiol. 1991; 133:940-951.
17. Strebel PM, Sutter RW, Cocbi SL. Epidemiology of poliomyelitis in the US. Clin Infect Dis. 1992;14:568-579.